<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03135353</url>
  </required_header>
  <id_info>
    <org_study_id>ED200417</org_study_id>
    <nct_id>NCT03135353</nct_id>
  </id_info>
  <brief_title>Saline Sonohystrography and Office Hysteroscopy in Evaluation of Cases of Abnormal Uterine Bleeding</brief_title>
  <official_title>Comparison Between 3D Saline Infusion Sonohystrography and Office Hysteroscopy in the Evaluation of Patients With Irregular Uterine Bleeding</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Woman's Health University Hospital, Egypt</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Woman's Health University Hospital, Egypt</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      comparing the efficacy of the 3D saline infusion sonohysterography to the diagnostic office
      hysteroscopy in the diagnosis of the cause of abnormal uterine bleeding in females during
      their reproductive age
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 20, 2017</start_date>
  <completion_date type="Anticipated">July 30, 2018</completion_date>
  <primary_completion_date type="Anticipated">July 25, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Sequential Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>effectiveness of SIS versus office hysteroscopy in the diagnosis of cause of AUB</measure>
    <time_frame>6 months</time_frame>
    <description>The results of the two procedures would be compared with the operative findings and later histopathological assessment of the specimens</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">250</enrollment>
  <condition>Gynecologic Disease</condition>
  <arm_group>
    <arm_group_label>3D saline infusion sonohysterography</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>participants presenting with abnormal uterine bleeding will undergo 3D saline infusion sonohysterography</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Office hysteroscopy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>after undergoing 3D SIS, cases would undergo office hysteroscopy and the investigator would be blinded to the results of SIS</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>3D saline infusion sonohysterography</intervention_name>
    <description>instillation of saline in the uterine cavity using pediatric foley's catheter, then performing 3D ultrasound scan of the uterus and adenexae</description>
    <arm_group_label>3D saline infusion sonohysterography</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Office Hysteroscopy</intervention_name>
    <description>an outpatient procedure done to assess the uterine cavity using the office hysteroscopy</description>
    <arm_group_label>Office hysteroscopy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  female aged between 20 and 45 years

          -  with no medical disorders

          -  approving to participate in the study

        Exclusion Criteria:

          -  vaginal or cervical lesions

          -  history or suspicion of PID

          -  IUD users

          -  bleeding disorders

          -  on anticoagulant therapy

          -  irregular use of oral contraceptive pills
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dina MR Dakhly, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cairo University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Dina MR Dakhly, MD</last_name>
    <phone>01003498919</phone>
    <phone_ext>002</phone_ext>
    <email>dinadakhly@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Yasmin A Bassiouny, MD</last_name>
    <phone>01001720751</phone>
    <phone_ext>002</phone_ext>
    <email>y_bas@hotmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Kasr el ainy hospital</name>
      <address>
        <city>Cairo</city>
        <zip>12211</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dina M Dakhly, M.D.</last_name>
      <phone>01003498919</phone>
      <phone_ext>+2</phone_ext>
      <email>Dinadakhly@mail.com</email>
    </contact>
    <investigator>
      <last_name>Dina M Dakhly, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 20, 2017</study_first_submitted>
  <study_first_submitted_qc>April 25, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 1, 2017</study_first_posted>
  <last_update_submitted>May 5, 2018</last_update_submitted>
  <last_update_submitted_qc>May 5, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 8, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Woman's Health University Hospital, Egypt</investigator_affiliation>
    <investigator_full_name>Dina Mohamed Refaat Dakhly</investigator_full_name>
    <investigator_title>Assistant Professor Obstetrics and Gynecology</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Uterine Hemorrhage</mesh_term>
    <mesh_term>Genital Diseases, Female</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

